FDA Inspection
Stira Pharmaceuticals LLCStira Pharmaceuticals LLC – FDA Inspection, Apr 6, 2026
Record Details
This FDA Inspection record concerns Stira Pharmaceuticals LLC, with an inspection on April 6, 2026, issued by the New Jersey District Office, covering human drugs.
View Company Profile
ID · 51e612af-013f-4522-9580-6b73d28692c3
Inspection Facts
- Inspection number
- 1311210
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Stira Pharmaceuticals LLC
1| Date | Classification | Office | Project area |
|---|---|---|---|
| November 5, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Stira Pharmaceuticals LLC
- FDA Inspection 1157218 - 2021-11-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.